surmount-1 trial tirzepatide weight loss nondiabetic reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism Leveraging the Individualized Metabolic Surgery

They concluded that perhaps LC does not interact with CrNic to cause improvement in reproductive parameters [20]

Weight regain is possible when stopping GLP-1 medications, as the appetite-suppressing effects diminish

Contact us or drop in to book your consultation today and let us help you take the first step towards a healthier, more confident future

While very uncommon with proper administration, it's important to be aware of more serious potential risks, often linked to improper techniques or unreliable products: Allergic Reactions: As with any substance, an allergic reaction (like rashes, hives, or difficulty breathing) is a slim possibility

Heat increases swelling and inflammation

To manage these, many providers recommend eating smaller, more frequent meals and staying hydrated